NAT2 and NQO1 polymorphisms are not associated with adult glioma.
Peters
E S
ES
Department of Cancer Cell Biology, Harvard University, Boston, Massachusetts 02115, USA.
Kelsey
K T
KT
Wiencke
J K
JK
Park
S
S
Chen
P
P
Miike
R
R
Wrensch
M R
MR
D000328:Adult; D017677:Age Distribution; D001191:Arylamine N-Acetyltransferase / Q000235:genetics*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics*; D016022:Case-Control Studies; D016001:Confidence Intervals; D005260:Female; D005910:Glioma / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000235:genetics*; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D012016:Reference Values; D012307:Risk Factors; D012494:Sampling Studies; D012495:San Francisco / Q000453:epidemiology; D017678:Sex Distribution
D016660:NAD(P)H Dehydrogenase (Quinone); D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human